Journal of Clinical Epidemiology
Volume 53, Issue 11 , Pages 1145-1149 , November 2000

Competing risks in absence of independence: Impact of AIDS on liver function failure mortality, and lung cancer on ischemic heart disease mortality

  • Javier Llorca

      Affiliations

    • Division of Preventive Medicine and Public Health, University of Cantabria School of Medicine, Av. Cardenal Herrera Oria s/n 39011-Santander, Spain
    • Corresponding Author InformationCorresponding author. Tel. 34-942 201 993; fax: 34-942 201 903.(J. Llorca)
    • ,
  • Miguel Delgado-Rodrı́guez

      Affiliations

    • Division of Preventive Medicine and Public Health, University of Cantabria School of Medicine, Av. Cardenal Herrera Oria s/n 39011-Santander, Spain
    • Division of Preventive Medicine and Public Health, University of Jaen, Jaén, Spain

Received 1 December 1998 ,Revised 2 December 1999 ,Accepted 25 February 2000.

References 

  1. Crowder M. Identifiability crises in competing risks. International Statistical Review. 1994;62:379–391
  2. Cornfield J. The estimation of the probability of developing a disease in the presence of competing risks. Am J Pub Health. 1957;47:601–607
  3. Gail M. A review and critique of some models used in competing risk analysis. Biometrics. 1975;31:209–222
  4. Moeschberger ML. Life tests under competing causes of failure and the theory of competing risks. Biometrics. 1971;27:909–933
  5. Welch HG, Albertsen PC, Nease RF, Bubolz TA, Wasson JH. Estimating treatment benefits for the elderly (the effects of competing risks). Ann Intern Med. 1996;124:577–584
  6. Prentice RL, Kalbfleisch JD, Peterson AV, Flournoy N, Farewell VT, Breslow NE. The analysis of failure times in the presence of competing risks. Biometrics. 1978;34:541–554
  7. Chiang CL. Competing risks in mortality analysis. Annu Rev Publ Health. 1991;12:281–307
  8. Rothenberg RB. Competing mortality and progress against cancer. Epidemiology. 1994;5:197–203
  9. Van Haastrecht HJA, Van Ameijden EJC, Van den Hoek JAR, Mientjes GHC, Bax JS, Coutinho RA. Predictors in mortality in the Amsterdam Cohort of Human Immunodeficiency Virus (HIV)-positive and HIV-negative Drug Users. Am J Epidemiol. 1996;143:380–391
  10. Equipo Coordinador de la Encuesta . Encuesta Nacional de Salud, 1993. Rev San Hig Pub. 1994;68:121–178
  11. Reducing the Health Consequences of Smoking: 25 Years of Progress: A Report of the Surgeon General (DHHS publication No. (CDC) 90-8416). Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control, Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 1990.
  12. Keyfitz N. What difference would it make if cancer were eradicated? An examination of the Taeuber paradox. Demography. 1977;14:411–418

PII: S0895-4356(00)00231-6

Journal of Clinical Epidemiology
Volume 53, Issue 11 , Pages 1145-1149 , November 2000

Article Tools